Finances: What you need to know about Exchange Traded Funds

Article

An exchange-traded fund can offer an inexpensive way to diversify an investment portfolio.

Key Points

Like closed-end funds, ETFs can be traded on a secondary market and thus have a market price that may be higher or lower than their net asset value (NAV). The NAV is the total value of a fund's assets less the liabilities. If the ETF shares trade at a price above their NAV, then they are said to be trading at a premium. Conversely, if they are trading at a price below their NAV, then they are said to be trading at a discount.

Typically, ETFs track stock indexes and are offered through a variety of well-known companies, including Standard & Poor's, Dow Jones, Vanguard, Merrill Lynch, and Barclays. The oldest and biggest ETF, Standard & Poor's Depositary Receipts (SPDRs, pronounced "spiders") tracks the S&P 500 index. It began trading on the American Stock Exchange under the symbol SPY. Because exchange-traded funds track specific indexes, their price fluctuates with the performance of the index. The companies and ETFs discussed herein are for illustrative purpose only and not a recommendation for the purchase of those specific securities.

ETFs track a wide variety of market indexes, the most prominent being equity indexes. ETF funds also include fixed-income securities, commodities, and currencies, and they cover both domestic and international indexes. In addition, exchange-traded funds may be based on certain characteristics such as market capitalization (small-, large-, and mid-cap stocks) or investment styles such as growth, value, and blend.

ETFs can be used to diversify across different sectors such as health care, technology, real estate, and utilities. Some ETFs track certain characteristics such as dividend-paying stocks. For example, ETFs may track a group of securities that have a number of consecutive years of dividend growth. Another variation may be an ETF that tracks an index that consists of the 100 highest-yielding stocks with dividends that are equal to or greater than dividends paid 5 years ago. Some ETFs permit shareholders to reinvest their dividends to purchase additional ETF shares.

A fast-growing investment vehicle

Innovative offerings have made ETFs one the fastest-growing investment vehicles in the financial industry. ETFs are a popular investment choice among both active and passive investors because of their flexibility to trade like a stock and instant diversification in the form of an index fund. Keep in mind that diversification does not eliminate the risk of investment losses.

The U.S. market accounts for the largest volume of ETFs in the world. Figure 1 illustrates the increase in the number and total assets of exchange-traded funds since 1995. Due to an increasing demand from investors in recent years, ETF assets have nearly doubled every 2 years. In 2008, the total number of ETFs rose to 728, with assets worth about $531 billion.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.